Clinical Relevance of the HD sEMG Signals in the Post-stroke Rehabilitation
NCT ID: NCT05849896
Last Updated: 2024-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
40 participants
INTERVENTIONAL
2023-03-13
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electrically Assisted Movement Therapy
NCT02563886
Impact of a Focal Muscle Vibration Protocol in Front of the the Anterior Tibial Muscle in the Subacute Post-stroke Period on Motor Recovery in Hemiplegic Patients.
NCT04737018
Upper Extremity Recovery Post Stroke Using Virtual Occupations
NCT03886480
Percutaneous Ultrasound-guided Neuromodulation to Improve Gait Rehabilitation in Patients Who Have Suffered a Stroke.
NCT07196878
Effects of Robotic Rehabilitation in Post-Stroke Patients
NCT04494685
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Static contractions in healthy volunteers
Acquisition of HD SEMG signals of an upper limb muscle and a lower limb muscle while the participant executes simple static exercises.
Acquisition of HD sEMG signals using the WPM-SEMG device
The WPM-SEMG-V2 device will be placed over the muscle of the participant to be investigated. A reference electrode over a bone close to the muscle of investigation will be applied. A sensor combing an accelerometer, gyroscope and magnetometer integrated in the WPM-SEMG-V2 device will be also used for the acquisition of body movement measures. An additional component for trapezoidal force measurement will be used during the acquisition in static contractions to measure the force. The participant will be instructed by the investigator how to execute the static or the dynamic exercises. Visual feedback will help the subject to track the trajectory.
Dynamic contractions in healthy volunteers
Acquisition of HD SEMG signals of a leg muscle while the participant executes simple dynamic exercises.This arm will recruited recreationally active or athletic volunteers, preferably between 18 and 20 years
Acquisition of HD sEMG signals using the WPM-SEMG device
The WPM-SEMG-V2 device will be placed over the muscle of the participant to be investigated. A reference electrode over a bone close to the muscle of investigation will be applied. A sensor combing an accelerometer, gyroscope and magnetometer integrated in the WPM-SEMG-V2 device will be also used for the acquisition of body movement measures. An additional component for trapezoidal force measurement will be used during the acquisition in static contractions to measure the force. The participant will be instructed by the investigator how to execute the static or the dynamic exercises. Visual feedback will help the subject to track the trajectory.
Static contractions in post-stroke patients
Acquisition of HD SEMG signals of a lower limb muscle while the participant executes simple static exercises.
Acquisition of HD sEMG signals using the WPM-SEMG device
The WPM-SEMG-V2 device will be placed over the muscle of the participant to be investigated. A reference electrode over a bone close to the muscle of investigation will be applied. A sensor combing an accelerometer, gyroscope and magnetometer integrated in the WPM-SEMG-V2 device will be also used for the acquisition of body movement measures. An additional component for trapezoidal force measurement will be used during the acquisition in static contractions to measure the force. The participant will be instructed by the investigator how to execute the static or the dynamic exercises. Visual feedback will help the subject to track the trajectory.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acquisition of HD sEMG signals using the WPM-SEMG device
The WPM-SEMG-V2 device will be placed over the muscle of the participant to be investigated. A reference electrode over a bone close to the muscle of investigation will be applied. A sensor combing an accelerometer, gyroscope and magnetometer integrated in the WPM-SEMG-V2 device will be also used for the acquisition of body movement measures. An additional component for trapezoidal force measurement will be used during the acquisition in static contractions to measure the force. The participant will be instructed by the investigator how to execute the static or the dynamic exercises. Visual feedback will help the subject to track the trajectory.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written Informed Consent
* Female or male
* 18 years or older
* Ability to understand the investigation
* Willingness to complete all the investigation assessments
* Ability to perform the procedures of the investigation
* Ability to perform maximal voluntary muscle extension of the target muscle and limb
* Subjects who participated in at least 150 min of moderate activity per week over the last six months.
* between 18 and 20 years (preferably)
Post-stroke patients
* Written informed consent
* Female or male
* 18 years or older
* Have a first-time stroke
* Ability to perform maximal voluntary muscle extension of the target muscle and limb
* Preserved cognitive capacity to perform the task
* Ability to understand the investigation
* Willingness to complete all the investigation assessments
* Ability to perform the procedures of the investigation
Exclusion Criteria
* Any significant acute disease state
* Skin disorders/allergies at the site of contact with the investigational device
* History of skin disease
* Known hypersensitivity or allergy to component of the investigational product (e.g. metal alloys) or other materials used (e.g., abrasive gel, foam with polystyrene markers)
* Chronic use of medications or treatment
Post-stroke patients
* History of spinal cord injury or traumatic brain damage
* Serious medical illness that precludes performing the task
* Severe locomotion disorder due to other causes
* Severe neurological disease other than stroke
* Any significant acute disease state
* Skin disorders/allergies at the site of contact with the investigational device
* History of skin disease
* Known hypersensitivity or allergy to component of the investigational product (e.g. metal alloys) or other materials used (e.g., abrasive gel, foam with polystyrene markers)
18 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Applied Sciences and Arts of Southern Switzerland
OTHER
Clinical Trial Unit Ente Ospedaliero Cantonale
OTHER
Alain Kaelin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alain Kaelin
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alain Kaelin, Prof.
Role: STUDY_DIRECTOR
Istituto di Neuroscienze Cliniche della Svizzera Italiana
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istituto di Neuroscienze Cliniche della Svizzera Italiana
Lugano, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SUPSI-SEMG-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.